Invention Grant
- Patent Title: Use of C1 inhibitor for the prevention of ischemia-reperfusion injury
-
Application No.: US13271107Application Date: 2011-10-11
-
Publication No.: US08415288B2Publication Date: 2013-04-09
- Inventor: Maurice Mannesse , Johannes Henricus Nuijens , Frank Pieper , Maria Grazia De Simoni , Gijsbertus Johannes Ziere
- Applicant: Maurice Mannesse , Johannes Henricus Nuijens , Frank Pieper , Maria Grazia De Simoni , Gijsbertus Johannes Ziere
- Applicant Address: NL Leiden
- Assignee: Pharming Intellectual Property B.V.
- Current Assignee: Pharming Intellectual Property B.V.
- Current Assignee Address: NL Leiden
- Agency: Alston & Bird LLP
- Priority: EP05112630 20051221
- Main IPC: C07K14/00
- IPC: C07K14/00
Abstract:
The present invention relates to the therapeutic and prophylactic use of C1 inhibitor for preventing, reducing and treating ischemia and reperfusion injury. The C1 inhibitor of the present invention is still therapeutically effective when administered after an ischemic period and reperfusion and therefore particularly useful for unforeseen occurrences of ischemic reperfusion such as e.g. a stroke.
Public/Granted literature
- US20120088728A1 USE OF C1 INHIBITOR FOR THE PREVENTION OF ISCHEMIA-REPERFUSION INJURY Public/Granted day:2012-04-12
Information query
